Mannatech (NASDAQ:MTEX) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a report released on Monday morning. The brokerage issued a buy rating on the stock.

Mannatech Stock Performance

MTEX opened at $8.40 on Monday. Mannatech has a 12 month low of $6.75 and a 12 month high of $10.51. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. The stock has a 50-day moving average of $7.79 and a 200 day moving average of $7.54. The firm has a market cap of $15.79 million, a P/E ratio of -10.37 and a beta of 1.17.

Mannatech (NASDAQ:MTEX) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) earnings per share for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%. The firm had revenue of $31.73 million during the quarter.

Insider Transactions at Mannatech

In other Mannatech news, Director Larry A. Jobe sold 16,288 shares of the company’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total value of $126,232.00. Following the completion of the sale, the director now directly owns 54,721 shares in the company, valued at $424,087.75. This represents a 22.94 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 41.50% of the company’s stock.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.